The mRNA Gold Rush: Why Moderna's "Cancer Vaccine" Hype Will Get Challenged

Mega-dose weekly mRNA part of toxic chemotherapy, however with rapid FDA approval, Intismeran poised to saddle patients with massive costs, tumor resistance, and accumulating long term safety concerns